Since ACE2, which functions as the viral entry receptor, is expressed not only in the epithelial and endothelial cells of the lungs, heart, and intestines but also in various neuronal cell types, including dopaminergic (DA) neurons [20,21,22], the concerns regarding the potential neurological effects of COVID-19 have arisen. This evidence concerns the gene ACE2 and COVID-19.